chr1-203216965-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000367229.6(CHIT1):āc.1325C>Gā(p.Ala442Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 1,614,100 control chromosomes in the GnomAD database, including 12,183 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A442V) has been classified as Likely benign.
Frequency
Consequence
ENST00000367229.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHIT1 | NM_003465.3 | c.1325C>G | p.Ala442Gly | missense_variant | 11/11 | ENST00000367229.6 | NP_003456.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHIT1 | ENST00000367229.6 | c.1325C>G | p.Ala442Gly | missense_variant | 11/11 | 1 | NM_003465.3 | ENSP00000356198 | P1 |
Frequencies
GnomAD3 genomes AF: 0.119 AC: 18101AN: 152126Hom.: 1161 Cov.: 33
GnomAD3 exomes AF: 0.125 AC: 31316AN: 251060Hom.: 2107 AF XY: 0.122 AC XY: 16498AN XY: 135712
GnomAD4 exome AF: 0.120 AC: 175693AN: 1461856Hom.: 11011 Cov.: 33 AF XY: 0.120 AC XY: 86984AN XY: 727228
GnomAD4 genome AF: 0.119 AC: 18150AN: 152244Hom.: 1172 Cov.: 33 AF XY: 0.121 AC XY: 9032AN XY: 74424
ClinVar
Submissions by phenotype
Chitotriosidase deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 22, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at